U.S. markets open in 4 hours 49 minutes
  • S&P Futures

    4,038.00
    -20.75 (-0.51%)
     
  • Dow Futures

    33,296.00
    -212.00 (-0.63%)
     
  • Nasdaq Futures

    12,940.25
    -58.25 (-0.45%)
     
  • Russell 2000 Futures

    2,118.80
    -12.70 (-0.60%)
     
  • Crude Oil

    64.52
    -1.56 (-2.36%)
     
  • Gold

    1,814.30
    -8.50 (-0.47%)
     
  • Silver

    27.01
    -0.23 (-0.86%)
     
  • EUR/USD

    1.2085
    +0.0009 (+0.07%)
     
  • 10-Yr Bond

    1.6950
    0.0000 (0.00%)
     
  • Vix

    27.62
    +5.78 (+26.47%)
     
  • GBP/USD

    1.4045
    -0.0012 (-0.09%)
     
  • USD/JPY

    109.5000
    -0.1600 (-0.15%)
     
  • BTC-USD

    50,513.15
    -6,375.26 (-11.21%)
     
  • CMC Crypto 200

    1,376.96
    -186.87 (-11.95%)
     
  • FTSE 100

    6,845.56
    -159.07 (-2.27%)
     
  • Nikkei 225

    27,448.01
    -699.50 (-2.49%)
     

AC Immune: 1Q Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

LAUSANNE, Switzerland (AP) _ AC Immune SA (ACIU) on Wednesday reported first-quarter net income of $63.8 million, after reporting a loss in the same period a year earlier.

The Lausanne, Switzerland-based company said it had net income of 91 cents per share. Earnings, adjusted for non-recurring gains, came to 85 cents per share.

The biopharmaceutical company posted revenue of $75.3 million in the period.

AC Immune shares have decreased 46% since the beginning of the year. The stock has declined 49% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACIU at https://www.zacks.com/ap/ACIU